Household pollution and obstructive diseases: asthma and COPD
J. Chatkin (Porto Alegre (RS), Brazil)
|   |
E-cigarettes and smoking cessation: the evidence or the non-evidence
C. Pisinger (Frederiksberg, Denmark)
| |
Preliminary evaluation of serial interferon-gamma releasing assay testing in NSCLC patients treated with immune checkpoint inhibitors
K. Fujita (Kyoto, Japan), Y. Yamamoto (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan)
|   |
The impact of anti-IgE treatment on the airway microbiome in asthma.
A. Sullivan (Cork, Ireland), C. Ward (Newcastle upon Tyne, United Kingdom), D. Casey (Cork, Ireland), D. Flynn (Cork, Ireland), E. Hunt (Cork, Ireland), J. Eustace (Cork, Ireland), P. O' Byrne (Hamilton, Ontario, Canada), B. Plant (Cork, Ireland), J. Macsharry (Cork, Ireland), D. Murphy (Cork, Ireland)
| |
Maternal and perinatal obesity arrests alveolarization and reduces alveolar progenitor cells in offspring
J. Selle (Cologne, Germany), K. Dinger (Cologne, Germany), H. Kesler (Cologne, Germany), T. Georgomanolis (Cologne, Germany), C. Vohlen (Cologne, Germany), R. Wilke (Cologne, Germany), J. Dötsch (Cologne, Germany), M. Alejandre Alcazar (Cologne, Germany)
| |
Plasmacytoma
C. Ortega Michel (San Sebastian, Spain)
| |
Liquid biopsy in patients with adenocarcinoma -comparison between bronchoalveolar lavage (BAL) and blood samples
N. Yanev (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), S. Bichev (Sofia, Bulgaria), A. Savov (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria)
| |
Concordance between pulmonologist performed rapid on-site evaluation (ROSE) and pathological diagnosis in EBUS-TBNA samples
M. Perez Morales (Marbella, Spain), M. Morales González (Cádiz, Spain), C. García Polo (Cádiz, Spain), E. González-Moya Rodriguez De Mondelo (Cádiz, Spain), M. Merino Sánchez (Cádiz, Spain)
| |
Endosonography for left adrenal gland assessment in lung cancer patients – 10 years experience
S. Orzechowski (Zakopane, Poland), M. Gnass (Zakopane, Poland), J. Sola (Zakopane, Poland), M. Lis (Zakopane, Poland), M. Skrobot (Zakopane, Poland), P. Gwózdz (Zakopane, Poland), A. Filarecka (Zakopane, Poland), J. Soja (Cracow, Poland), J. Pankowski (Zakopane, Poland), A. Bartczak (Zakopane, Poland), A. Szlubowski (Zakopane, Poland)
| |
Pulmonary functional diagnosis of COPD
Z. Aisanov (Moscow, Russian Federation)
| |
Classification of COPD: problems and controversies
K. Kostikas (Ioannina, Greece)
| |
Pathomorphology of COPD
M. Samsonova (Moscow, Russian Federation)
| |
Histopathological comparison of endobronchial biopsies from different pulmonary lobes of severe asthmatic patients
M. Karakioulaki (Basel, Switzerland), T. Koletsa (Thessaloniki, Greece), E. Papakonstantinou (Basel, Switzerland), S. Savic (Basel, Switzerland), K. Jahn (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Categorization of asthma patients by Global Initiative for Asthma (GINA) 2018 guidelines using a US administrative claims database
M. Castro (Kansas City, United States of America), M. Mychaskiw (West Chester, United States of America), S. Lim (West Chester, United States of America), R. Brown (West Chester, United States of America), S. Colilla (West Chester, United States of America)
| |
Real world residual disease manifestations after 2-years anti-IL-5 treatment for severe asthma
K. Eger (Amsterdam, Netherlands), J. Kroes (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands), J. Sont (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands)
| |
Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify asthma-COPD overlap
T. Shirai (Shizuoka, Japan), K. Hirai (Shizuoka, Japan), Y. Gon (Tokyo, Japan), S. Maruoka (Tokyo, Japan), K. Mizumura (Tokyo, Japan), M. Hikichi (Tokyo, Japan), K. Itoh (Shizuoka, Japan), S. Hashimoto (Tokyo, Japan)
| |
Early-life exposure to air pollution and lung function development into adolescence: the GINIplus/LISA birth cohorts
Q. ZHAO (Düsseldorf, Germany), I. Markevych (Krakow, Poland), D. Berdel (Wesel, Germany), A. Berg (Wesel, Germany), M. Gappa (Düsseldorf, Germany), S. Koletzko (Munich, Germany), C. Bauer (Munich, Germany), H. Schulz (Neuherberg, Germany), M. Standl (Neuherberg, Germany), J. Heinrich (Neuherberg, Germany), T. Schikowski (Düsseldorf, Germany)
| |
Pollen exposure in pregnancy and infancy and risk of childhood asthma
C. Lundholm (Stockholm, Sweden), C. Almqvist (Stockholm, Sweden), S. Ekberg (Stockholm, Sweden), F. Fang (Stockholm, Sweden), T. Fall (Uppsala, Sweden), Å. Dahl (Göteborg, Sweden)
| |
Respiration monitoring in COPD patients
D. Blanco-Almazán (Barcelona, Spain)
| |
Activation of toxicology-related genes in human airway constructs after exposure to indoor air particulate matter from moisture-damaged houses
M. Nordberg (Kuopio, Finland), M. Täubel (Kuopio, Finland), H. Leppänen (Kuopio, Finland), A. Hyvärinen (Kuopio, Finland), K. Huttunen (Kuopio, Finland)
| |
Identification and characterisation of twenty-two novel SERPINA1 pathological mutations
S. Ottaviani (Pavia (PV), Italy), A. Fra (Brescia (BS), Italy), A. Balderacchi (Pavia (PV), Italy), V. Barzon (Pavia (PV), Italy), T. Carroll (Dublin, Ireland), D. Piloni (Pavia (PV), Italy), F. Mariani (Pavia (PV), Italy), N. Mc Elvaney (Dublin, Ireland), A. Corsico (Pavia (PV), Italy), I. Ferrarotti (Pavia (PV), Italy)
| |
Interaction between VGDF exposure and antioxidant genes on COPD in UK Biobank
D. van der Plaat (London, United Kingdom), S. De Matteis (Cagliari, Italy), S. Sadhra (Birmingham, United Kingdom), D. Jarvis (London, United Kingdom), P. Cullinan (London, United Kingdom), C. Minelli (London, United Kingdom)
| |
Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD
B. Degano (grenoble, France)
| |
PBF-680, an oral A1 adenosine receptor antagonist, inhibits the late allergic response (LAR) in mild-to-moderate atopic asthmatics: a Phase-IIa trial
D. Ramos-Barbon (Barcelona, Spain), N. Brienza (Barcelona, Spain), T. Bigorra Rodríguez (Barcelona, Spain), É. Mateus Medina (Barcelona, Spain), I. Gich Saladich (Barcelona, Spain), M. Puntes Rodríguez (Barcelona, Spain), R. Antonijoan Arbos (Barcelona, Spain), S. Quirce Gancedo (Madrid, Spain), N. Castro Palomino Laria (Barcelona, Spain), J. Castro Palomino Laria (Barcelona, Spain)
| |
Changes in DNA methylation after corticosteroids treatment in COPD patients
J. van Nijnatten (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), P. Hiemstra (Leiden, Netherlands), W. Timens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), A. Faiz (Sydney, Australia)
| |
Azithromycin prevents airway epithelial barrier dysfunction induced by sulphur dioxide inhalation
J. Kricker (REYKJAVIK, Iceland), T. Gudjonsson (REYKJAVIK, Iceland), A. Arason (REYKJAVIK, Iceland), J. Joelsson (REYKJAVIK, Iceland), B. Valdimarsdottir (REYKJAVIK, Iceland), F. Gardarsson (REYKJAVIK, Iceland), C. Page (LONDON, United Kingdom), F. Lehmann (REYKJAVIK, Iceland), S. Ingthorsson (REYKJAVIK, Iceland)
| |
Inhaled corticosteroid (ICS) induced metabolome changes in asthmatics.
P. Daley-Yates (Uxbridge, United Kingdom), B. Keppler (Morrisville, United States of America), N. Brealey (Uxbridge, United Kingdom), S. Shabbir, (Stevenage, United Kingdom), D. Singh (Manchester, United Kingdom), N. Barnes (Brentford, United Kingdom)
| |
Lung microbial factors as drivers for COPD
M. Hilty (Bern, Switzerland)
| |
Bacterial dysbiosis in pediatric lung diseases such as asthma and CF
A. Dalpke (Dresden, Germany)
| |
Cellular senescence in regeneration and diseases of the lung
M. Lehmann (München, Germany)
| |
Senescence and immune ageing
M. Rojas (Pittsburgh, United States of America)
| |
Targeting the lung epithelium: does age matter?
P. Wolters (San Francisco, United States of America)
| |
Severe asthma guidelines: 2019 update
R. Buhl (Mainz, Germany)
| |
ICS discontinuation guidelines in COPD
D. Stolz (Basel, Switzerland)
| |
Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD
S. Cloonan (New York City, United States of America)
| |
Sing-a-Lung: Group singing as training modality in pulmonary rehabilitation for patients with Chronic Obstructive Pulmonary Disease (COPD): A multicenter, cluster-randomised, non-inferiority controlled trial
M. Kaasgaard (Copenhagen, Denmark), D. Bech Rasmussen (Naestved, Denmark), A. Løkke Ottesen (Vejle, Denmark), P. Vuust (Aarhus, Denmark), O. Hilberg (Vejle, Denmark), U. Bodtger (Naestved, Denmark)
| |
Spirometric phenotypes from early childhood to young adulthood – A CADSET (Chronic Airway Disease Early Stratification) study
E. Melén (Stockholm, Sweden), J. Hallberg (Stockholm, Sweden), H. Backman (Umeå, Sweden), E. Baraldi (Padova, Italy), R. Breyer-Kohansal (Vienna, Austria), M. Casas (Barcelona, Spain), F. Chung (London, United Kingdom), L. Duijts (Rotterdam, Netherlands), R. Granell (Bristol, United Kingdom), T. Sigsgaard (Aarhus, Denmark), M. Van Der Berge (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), E. Heuvelin (Lausanne, Switzerland), R. Faner (Barcelona, Spain), G. Donaldson (London, United Kingdom), J. Wedzicha (London, United Kingdom), A. Agusti (Barcelona, Spain), A. Maitland Van Der Zee (Amsterdam, Netherlands)
| |
Does the endotype-driven approach translate into improved quality of life?
B. Flood (Gorey, Ireland)
| |
Linking clinical algorithms to precision medicine
M. Bonini (Rome, Italy)
| |
Upper airways in asthmatic patients
A. Bossios (Stockholm, Sweden)
| |
High-dimensional multivariable analysis of asthma and its co-morbidities
B. Schaub (Munich, Germany)
| |
Allergy testing and immunotherapy guidelines
I. Agache (Brasov (Brasov), Romania)
| |
Wrap-up by discussant and discussion
M. Gaga (Athens, Greece)
| |
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
T. Hardman (Kingston-Upon-Thames, United Kingdom), L. Heaney (Belfast, United Kingdom), J. Busby (Belfast, United Kingdom), C. Hanratty (Belfast, United Kingdom), R. Djukanovic (Southampton, United Kingdom), A. Woodcock (Manchester, United Kingdom), S. Walker (London, United Kingdom), J. Arron (California,, United States of America), D. Choy (California, United States of America), P. Bradding (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), D. Cowan (Glasgow, United Kingdom), R. Niven (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), T. Harrison (Nottingham, United Kingdom), P. Howarth (Southampton, United Kingdom), J. Lordan (Newcastle, United Kingdom), A. Mansur (Birmingham, United Kingdom), A. Menzies-Gow (London, United Kingdom), D. Robinson (London, United Kingdom)
| |
Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT): a randomized controlled trial
T. Ruffles (Brighton, United Kingdom), C. Jones (Guildford, United Kingdom), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), J. Grigg (London, United Kingdom), R. Tavendale (Dundee, United Kingdom), F. Hogarth (Dundee, United Kingdom), P. Rauchhaus (Dundee, United Kingdom), K. Pilvinyte (Dundee, United Kingdom), H. Smith (Brighton, United Kingdom), R. Littleford (Brisbane, Australia), B. Lipworth (Dundee, United Kingdom), S. Mukhopadhyay (Brighton, United Kingdom)
| |
Modeling the regenerative potential of airway epithelial cells
P. Hiemstra (Leiden, Netherlands)
| |
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), X. Yao (Oxford, United Kingdom), M. Abd Hamid (Oxford, United Kingdom), T. Dong (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Dobson (Oxford, United Kingdom), S. Montefort (Msida, Malta), P. Fsadni (Msida, Malta), N. Rahman (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom)
| |
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
J. Ferguson (Glasgow, United Kingdom), C. Craig (Manchester, United Kingdom), V. Randles (Cheshire, United Kingdom), T. Taylor (Cheshire, United Kingdom), L. Brown (Manchester, United Kingdom), D. Fullerton (Cheshire, United Kingdom), M. Evison (Manchester, United Kingdom), K. Blyth (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom)
| |
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |
Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong)
| |
BAP1 loss predicts longer survival for mesothelioma patients treated with pemetrexed-based chemotherapy.
V. Panou (Odense & Aalborg, Denmark), A. Louw (Perth, Australia), W. Szejniuk (Aalborg, Denmark), C. Meristoudis (Aalborg, Denmark), S. Chai (Perth, Australia), L. Lynggård Andersen (Aalborg, Denmark), A. Birbaneh Asghari (Aalborg, Denmark), M. Vyberg (Aalborg, Denmark), J. Hansen (Copenhagen, Denmark), J. Creaney (Perth, Australia), O. Røe (Levanger & Trondheim, Norway)
| |
Is it more than just asthma?
M. Proesmans (Leuven, Belgium)
| |
Thoracic ultrasound: pleural effusion and empyema
N. Rahman (Oxford, United Kingdom)
| |
Non-invasive ventilation can modulate the responses of vascular reactivity in COPD-HF patients to high-intensity exercise
C. Goulart (São Carlos, Brazil), F. Caruso (São Carlos, Brazil), A. Araújo (São Carlos, Brazil), P. Santos (São Carlos, Brazil), G. Arêas (São Carlos, Brazil), G. Casale (São Carlos, Brazil), R. Mendes (São Carlos, Brazil), A. Da Silva (Santa Cruz do Sul, Brazil), A. Borghi-Silva (São Carlos, Brazil)
| |
Exertional dyspnea in COPD: the dominant role of increased diaphragmatic activation
. James (Kingston, Canada), K. Milne (Kingston, Canada), M. Ibrahim Masthan (Kingston, Canada), J. Neder (Kingston, Canada), D. O'Donnell (Kingston, Canada)
| |
Oxygen uptake measured at the ventilatory threshold is a mortality marker in COPD
T. Georges (Nantes, France), S. Courat (Nantes, France), M. Le Vaillant (Beaucouzé, France), H. Ouksel (Beaucouzé, France), A. Chambellan (Nantes, France)
| |
Acute health effects after passive e-vape among patients with COPD – an RCT exposure study
K. Rosenkilde Laursen (Aarhus, Denmark), J. H. Bønløkke (Ålborg, Denmark), M. Bilde (Aarhus, Denmark), M. Glasius (Aarhus, Denmark), E. Bendstrup (Aarhus, Denmark), S. K. Kjærgaard (Aarhus, Denmark), A. Olin (Gothenburg, Sweden), T. Sigsgaard (Aarhus, Denmark)
| |
Asthma do not counteract smoking initiation
L. Hedman (Umeå, Sweden), H. Backman (Umeå, Sweden), M. Andersson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), E. Rönmark (Umeå, Sweden)
| |
Outpatient smoking cessation: preliminary findings of a non-inferiority RCT comparing blended with face-to-face delivery mode
L. Siemer (Enschede, Netherlands), M. Pieterse (Enschede, Netherlands), S. Ben Allouch (Amsterdam, Netherlands), M. Postel (Enschede, Netherlands), R. Sanderman (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)
| |
Flavor-solvent reaction products in electronic cigarette liquids activate respiratory irritant receptors and elicit cytotoxic metabolic responses in airway epithelial cell
S. Jordt (Durham, NC, United States of America), A. Caceres (Durham, NC, United States of America), H. Erythropel (New Haven, CT, United States of America), J. Zimmerman (New Haven, CT, United States of America), T. Dewinter (New Haven, CT, United States of America), S. Jabba (Durham, NC, United States of America)
| |
Endobronchial ultrasound and trans-esophageal endobronchial ultrasound
J. Annema (Amsterdam, Netherlands), L. Crombag (Amsterdam, Netherlands)
| |
Multiple-breath washout and pulmonary function tests versus high-resolution computed tomography scores in adults with cystic fibrosis.
A. Cherniak (Moscow, Russian Federation), Z. Naumenko (Moscow, Russian Federation), S. Krasovskiy (Moscow, Russian Federation), K. Mikhailichenko (Moscow, Russian Federation), G. Nekludova (Moscow, Russian Federation)
| |
Air liquid interface (ALI)-grown immortalized human cell lines: a promising tractable model for human airway
Z. Alharbi (Sheffield, United Kingdom), M. Chowdhury (Sheffield, United Kingdom), L. Bingle (Sheffield, United Kingdom), C. Bingle (Sheffield, United Kingdom)
| |
Choice of pleural puncture site: Prospective comparative study between clinical exam and ultrasound
I. Mejri Ep Ajili (Tunis, Tunisia), M. Ferchichi (Tunis, Tunisia), M. Chaabane (Tunis, Tunisia), S. Mhamdi (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), Z. Moatemri (Tunis, Tunisia), M. Mohsen (Tunis, Tunisia)
| |
Anesthesia experience of EBUS/EUS-B
M. Oliveira (Guarda, Portugal), C. Mourato (Coimbra, Portugal), S. Pinho (Coimbra, Portugal), J. Silva (Guarda, Portugal), M. Santis (Coimbra, Portugal), L. Barradas (Coimbra, Portugal), P. Freitas (Coimbra, Portugal)
| |
Invasiveness assessment of deep leaning method for pulmonary subsolid nodules
J. Deng (Shanghai, China), Y. She (Shanghai, China), J. Wang (Shanghai, China), T. Wang (Shanghai, China), M. Zhao (Shanghai, China), Y. Wang (Shanghai, China), Y. Wen (Shanghai, China), X. Sun (Shanghai, China), D. Xie (Shanghai, China), C. Chen (Shanghai, China)
| |
Late Breaking Abstract - ACE2 expression in lower airway epithelial cells is increased with age and in males, but is less in asthma.
P. Wark (Newcastle (NSW), Australia), P. Pathinyake (New Lambton Heights (NSW), Australia), G. Kaiko (Newcastle, Australia), S. Sohal (Launceston (TAS), Australia), C. Oldmeadow (Newcastle, Australia), N. Bartlett (Newcastle, Australia), S. Stick (Perth, Australia), P. Hansbro (Sydney (NSW), Australia), A. Kicic (NPerth (WA), Australia)
| |
Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury
M. Kiener (Bern, Switzerland), L. De Maddalena (Bern, Switzerland), N. Roldan (Bern, Switzerland), G. Thalmann (Bern, Switzerland), T. Geiser (Bern, Switzerland), N. Hobi (Bern, Switzerland), M. Kruithof-De Julio (Bern, Switzerland)
| |
Late Breaking Abstract - Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
J. Chalmers (Dundee (Angus), United Kingdom), D. Cipolla (Hayword, United States of America), B. Thompson (Owings Mills, United States of America), A. Davis (Clayton, United States of America), A. O'Donnell (Washington, United States of America), G. Tino (Philadelphia, United States of America), I. Gonda (Hayward, United States of America), C. Haworth (Cambridge, United Kingdom), J. Froehlich (Hayward, United States of America)
| |
Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study
J. Chalmers (Dundee, United Kingdom), C. Haworth (Cambridge, United Kingdom), M. Metersky (Farmington, United States of America), M. Loebinger (London, United Kingdom), F. Blasi (Milan, Italy), O. Sibila (Barcelona, Spain), A. O'Donnell (Washington DC, United States of America), E. Sullivan (Bridgewater, NJ, United States of America), K. Mange (Bridgewater, NJ, United States of America), C. Fernandez (Bridgewater, NJ, United States of America), J. Zou (Bridgewater, NJ, United States of America), C. Daley (Dundee (Angus), United States of America)
| |
Efficacy of inhaled dry powder tobramycin (TOBI Podhaler) in P. aeruginosa infected patients with bronchiectasis - iBEST study
M. Loebinger (London, United Kingdom), E. Polverino (Barcelona, Spain), F. Blasi (Milan, Italy), S. Elborn (Belfast, United Kingdom), J. Chalmers (Scotland, United Kingdom), H. Tiddens (Rotterdam, Netherlands), H. Goossens (Antwerp, Belgium), M. Tunney (Belfast, United Kingdom), F. Ringshausen (Hannover, Germany), A. Hill (Edinburgh, United Kingdom), R. Pathan (Hyderabad, India), G. Angyalosi (Basel, Switzerland), C. Haworth (Cambridge, United Kingdom)
| |
Safety Analysis of Superior Vena Cava Resection for Extended Thymic Epithelial Neoplasms>
L. Bertolaccini (Milan, Italy), E. Prisciandaro (Milan, Italy), G. Sedda (Milan, Italy), L. Spaggiari (Milan, Italy)
| |
Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis
C. Pompili (Leeds, United Kingdom), K. Franks (Leeds, United Kingdom), Z. Rogers (Leeds, United Kingdom), M. Callister (Leeds, United Kingdom), J. Robson (Leeds, United Kingdom), A. Brunelli (Leeds, United Kingdom), P. Holch (Leeds, United Kingdom), W. Chia (Leeds, United Kingdom), K. Absolom (Leeds, United Kingdom), G. Velikova (Leeds, United Kingdom)
| |
Sublobar resection versus lobectomy in non-small cell lung cancer: a propensity matched analysis
A. Honguero Martinez (Albacete, Spain), C. Almonte-García (Albacete, Spain), M. Peyró-Sánchez (Albacete, Spain), M. Genovés-Crespo (Albacete, Spain), C. Sampedro-Salinas (Albacete, Spain), F. Callejas-González (Albacete, Spain), R. Godoy-Mayoral (Albacete, Spain), M. García-Jiménez (Albacete, Spain), C. Rodríguez-Ortega (Albacete, Spain), P. López-Miguel (Albacete, Spain), A. Núñez-Ares (Albacete, Spain), N. Gutiérrez-González (Albacete, Spain), W. Almonte-Batista (Albacete, Spain), J. Cruz-Ruiz (Albacete, Spain), S. García-Castillo (Albacete, Spain), M. Moscardó-Orenes (Albacete, Spain), J. Jiménez-López (Albacete, Spain), P. León-Atance (Albacete, Spain)
| |
Late Breaking Abstract - An updated meta-analysis of uniportal versus multiportal video-assisted thoracoscopic lobectomy for lung cancer.
D. Magouliotis (London, United Kingdom), M. Fergadi (Larisa, Greece), K. Spiliopoulos (Larisa, Greece), K. Athanassiadi (Athens, Greece)
| |
Is smoking a major risk factor for COVID-19 infection and severe disease?
F. Filippidis (Oxford, United Kingdom)
| |
Asthma, atopy and lung function in young adults hospitalised for bronchiolitis in infancy.
K. Sørensen (Stavanger, Norway), K. Øymar (Stavanger, Norway), T. Halvorsen (Bergen, Norway), I. Mikalsen (Stavanger, Norway)
| |
Padiatric Asthma in Canada 2016: A cross-sectional study in primary care
A. Cave (Edmonton, Canada), C. Gillies (Edmontonnton (AB), Canada), S. Aponte-Hao (Calgary, Canada), B. Soos (Calgary, Canada), T. Williamson (Calgary, Canada), N. Drummond (Edmonton, Canada)
| |
The role of eosinophils in pediatric and adult asthma
J. Omony (Neuherberg, Germany), R. Grychtol (Hannover, Germany), N. Maison (Munich, Germany), D. Thiele (Lübeck, Germany), A. Chari Jirmo (Hannover, Germany), A. Dittrich (Hannover, Germany), T. Bahmer (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), H. Renz (Marburg, Germany), G. Hansen (Hannover, Germany), M. Kopp (Lübeck, Germany), B. Schaub (Munich, Germany), E. Von Mutius (Neuherberg, Germany), S. Illi (Neuherberg, Germany)
| |
Identification of important respiratory research themes relevant to primary care: qualitative analysis of round 1 of the 2020 International Primary Care Respiratory Group (IPCRG) Research Prioritisation Exercise
A. Abdel-Aal (Hull/ York, United Kingdom), R. Jordan (Birmingham, United Kingdom), P. Adab (Birmingham, United Kingdom), R. Adam (Birmingham, United Kingdom), A. Barnard (Sydney, Australia), I. Bouloukaki (Crete, Greece), J. Boven (Groningen, Netherlands), N. Chavannes (Leiden, Netherlands), A. Dickens (Birmingham, United Kingdom), F. Gemert (Groningen, Netherlands), M. Escarrer (Mallorca, Spain), S. Haroon (Birmingham, United Kingdom), A. Kayongo (Kampala, Uganda), B. Kirenga (Kampala, Uganda), J. Kocks (Groningen, Netherlands), D. Kotz (Düsseldorf, Germany), K. Lisspers (Uppsala, Sweden), C. Newby (London, United Kingdom), C. Mcnulty (Gloucester, United Kingdom), E. Metting (Groningen, Netherlands), L. Moral (Alicante, Spain), S. Papadakis (Ottawa, Canada), H. Pinnock (Edinburgh, United Kingdom), D. Price (Singapore, Singapore), D. Ryan (Edinburgh, United Kingdom), S. Singh (Leicester, United Kingdom), J. Sousa ( Porto, Portugal), B. Ställberg (Uppsala, Sweden), S. Szefler (Colorado, United States of America), S. Taylor (London, United Kingdom), I. Tsiligianni (Crete, Greece), A. Turner (Birmingham, United Kingdom), D. Weller (Edinburgh, United Kingdom), S. Williams (England, United Kingdom)
| |
Comparison of first experience with different inhalers in COPD: a cross-over study
H. Harb (Beni-Suef, Egypt), N. Laz (Beni-Suef, Egypt), H. Rabea (Beni-Suef, Egypt), M. Abdelrahim (Beni-Suef, Egypt)
| |